明德生物：关于募集资金投资项目延期的公告

Core Viewpoint - Mingde Biological announced the postponement of fundraising investment projects, specifically the "In Vitro Diagnostic Products Construction Project" and the "Medical Health Informationization Project," without changing the implementation主体,方式, or用途 [2] Group 1 - The fifth meeting of the company's fifth board of directors will be held on December 12, 2025, to review the proposal for the postponement of fundraising investment projects [2] - The postponement only involves changes in project progress and does not require submission for shareholder meeting approval [2] - The adjusted timeline for the projects to reach the predetermined usable state has been agreed upon [2]